Previous 10 | Next 10 |
Short interest is often seen as a poor indicator for future price performance because it can represent conflicting signals. One one hand, its backward-looking as the stocks with the weakest operating and financial results typically decline against the market attracting further speculative sell...
TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced that the company will participate in the Bank of America Merrill Lynch 2019 Health Care Conference. Chief Executive Officer Robert G. Finizio will provide an overview of the company...
Catalyst Pharmaceuticals (NASDAQ: CPRX ) -39% after FDA OKs Firdapse competitor. More news on: Catalyst Pharmaceuticals, Inc., Intersect ENT, Inc., TherapeuticsMD, Inc., Stocks on the move, Read more ...
Biotech Stocks: Why Expensive U.S. Drug Trials Are Pushing Pharma Research Overseas May 7, 2019 Palm Beach, FL –May 7, 2019 – American pharmaceutical and biotech companies who need to conduct clinical trials are looking more and more to conduct them overseas in the Europe...
TherapeuticsMD, Inc. (TXMD) Q1 2019 Earnings Conference Call May 06, 2019 4:30 PM ET Company Participants Nichol Ochsner - Vice President, Investor Relations Robert Finizio - Chief Executive Officer Daniel Cartwright - Chief Financial Officer Dawn Halkuff - Chief Commercial Off...
Gainers: SEDG +18.5% . AVID +10.2% . APT +9.3% . AIG +6.4% . LCI +5.7% . More news on: SolarEdge Technologies, Inc., Avid Technology, Inc., Alpha Pro Tech, Ltd., Stocks on the move, Read more ...
The following slide deck was published by TherapeuticsMD, Inc. in conjunction with their 2019 Q1 earnings Read more ...
Therapeutics MD (NASDAQ: TXMD ): Q1 GAAP EPS of -$0.16 beats by $0.01 . More news on: TherapeuticsMD, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
BIJUVA™ Commercial Launch in April 2019 Completed $300 Million Non-Dilutive Term Loan Financing Facility in April 2019 IMVEXXY ® Continues Strong Positive Trends for Prescriptions and Patient Refills Conference Call Scheduled for 4:30 p.m. ET Today TherapeuticsMD, ...
Large Survey Exclusively Focused on Women’s Male Partners Reveals a Clear Negative Impact of Menopause on Relationships, Lack of Clarity About Symptoms and Treatments, and Men’s Willingness to Discuss and Influence Decisions TherapeuticsMD, Inc. (NASDAQ: TXMD), an innova...
News, Short Squeeze, Breakout and More Instantly...
TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Net Income (...
• Evaluation of strategic alternatives continues TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023...